March 16, 2016: Here are four stocks trading with heavy volume among 53 equities making new 52-week lows in Wednesday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped another 6.9% on Wednesday…
The top analyst upgrades, downgrades and initiations seen on Wednesday, March 16, include Chipotle Mexican Grill, Oracle, Orexigen Therapeutics, PulteGroup, Reynolds American and Valeant Pharmaceuticals.
CEO Michael Pearson needs to leave Valeant Pharmaceuticals for it to have any chance to recover. The company cannot afford to keep him.
Douglas A. McIntyre March 15, 2016: Here are four stocks trading with heavy volume among 33 equities making new 52-week lows in Tuesday’s session. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped by more than 51%…
Valeant Pharmaceuticals International reported mixed preliminary fourth-quarter financial results before the markets opened on Tuesday.
Chris Lange Valeant Pharmaceuticals is scheduled to report its fourth-quarter preliminary results and update its 2016 financial guidance in a conference call Tuesday morning.
Chris Lange Valeant Pharmaceuticals International CEO Michael Pearson needs to leave the company he leads, as its problems continue to grow rapidly.
Douglas A. McIntyre The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony, Urban Outfitters and Valeant Pharmaceuticals.
In Monday's trading session, it seems that investors are finally coming around and trusting Valeant Pharmaceuticals.
Chris Lange Although stocks are beginning to make a comeback at this time, there are still those that are caught in the downturn slowing this recovery and punishing their shareholders.
Canaccord Genuity has downgraded Valeant Pharmaceuticals due to the growing uncertainty surrounding its multitude of investigations, both internal and external.
Chris Lange March 1, 2016: Here are four stocks trading with heavy volume among 44 equities making new 52-week lows today. Valeant Pharmaceuticals International Inc. (NYSE: VRX) dropped about 9% on Tuesday to post…
The top analyst upgrades, downgrades and initiations seen on Tuesday, March 1, include Freeport-McMoRan, PTC Therapeutics, SunEdison, Transocean, United Technologies, Valeant Pharmaceuticals and Windstream.
Valeant Pharmaceuticals International Inc. (NYSE: VRX) CEOÂ J. Michael Pearson has returned from sick leave. It is a wonder the board has accepted him back, based on what has happened to the pharmaceuticals…
Douglas A. McIntyre Over the past week, Valeant Pharmaceuticals and a few other biotech companies made impressive runs, due to positive trial results and an FDA meeting.
Chris Lange 
